Entheon Biomedical Balance Sheet Health
Financial Health criteria checks 4/6
Entheon Biomedical has a total shareholder equity of CA$229.1K and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$249.3K and CA$20.2K respectively.
Key information
0%
Debt to equity ratio
CA$0
Debt
Interest coverage ratio | n/a |
Cash | CA$228.60k |
Equity | CA$229.13k |
Total liabilities | CA$20.19k |
Total assets | CA$249.32k |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1XU's short term assets (CA$244.3K) exceed its short term liabilities (CA$20.2K).
Long Term Liabilities: 1XU has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 1XU is debt free.
Reducing Debt: 1XU had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1XU has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 1XU has less than a year of cash runway if free cash flow continues to grow at historical rates of 41.5% each year.